Metronomic chemotherapy: An attractive alternative to maximum tolerated dose therapy that can activate anti-tumor immunity and minimize therapeutic resistance
Irina Kareva(Tufts Children's Hospital), Giannoula Klement(Tufts Medical Center)
Cited by 254
Related Papers
Predator-Prey in Tumor-Immune Interactions: A Wrong Model or Just an Incomplete One?
|Frontiers in Immunology|2021|50